NASDAQ : GDRX
GoodRx Holdings, Inc. — Key statistics
Healthcare · Health Information Services · United States
Last price 3.54 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.21B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.19B |
| Enterprise Value | 1.43B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 107.18M |
| Shares Outstanding | 341.15M |
| Shares Change (YoY) | -9.06% |
| Shares Change (QoQ) | +1.94% |
| Owned by Insiders (%) | 4.00% |
| Owned by Institutions (%) | 17.47% |
| Float | 93.77M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 73.53 |
| Forward PE | 32.31 |
| PS Ratio | 1.52 |
| Forward PS | 1.47 |
| PB Ratio | 1.83 |
| P/TBV Ratio | 63.61 |
| P/FCF Ratio | 6.04 |
| P/OCF Ratio | 5.91 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 88.22 |
| EV / Sales | 1.83 |
| EV / EBITDA | 13.18 |
| EV / EBIT | 16.06 |
| EV / FCF | 7.27 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.38 |
| Quick Ratio | 0.42 |
| Debt / Equity | 0.83 |
| Debt / EBITDA | 4.60 |
| Debt / FCF | 2.73 |
| Interest Coverage | 2.19 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 2.52% |
| Return on Assets (ROA) | 3.05% |
| Return on Invested Capital (ROIC) | 3.85% |
| Return on Capital Employed (ROCE) | 7.53% |
| Weighted Average Cost of Capital (WACC) | 10.26% |
| Revenue Per Employee | $1.13M |
| Profits Per Employee | $23,313 |
| Employee Count | 697 |
| Asset Turnover | 0.43 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 25.15M |
| Effective Tax Rate | 60.75% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.69 |
| 52-Week Price Change | -0.85% |
| 50-Day Moving Average | 3.43 |
| 200-Day Moving Average | 2.82 |
| Relative Strength Index (RSI) | 52.28 |
| Average Volume (20 Days) | 1,048,149 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3.67M |
| Short Previous Month | 4.16M |
| Short % of Shares Out | 1.08% |
| Short % of Float | 3.92% |
| Short Ratio (days to cover) | 4.43 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 785.23M |
| Gross Profit | 713.19M |
| Operating Income | 89.24M |
| Pretax Income | 41.40M |
| Net Income | 16.25M |
| EBITDA | 108.78M |
| EBIT | 89.24M |
| Earnings Per Share (EPS) | $0.05 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 296.11M |
| Total Debt | 538.95M |
| Net Cash | -242.84M |
| Net Cash Per Share | -$0.71 |
| Equity (Book Value) | 647.60M |
| Book Value Per Share | 1.90 |
| Working Capital | 441.46M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 201.58M |
| Capital Expenditures | -4.49M |
| Depreciation & Amortization | 19.54M |
| Net Borrowing | -5.00M |
| Free Cash Flow | 197.09M |
| FCF Per Share | $0.58 |
Margins
| Measure | Value |
|---|
| Gross Margin | 90.83% |
| Operating Margin | 11.36% |
| Pretax Margin | 5.27% |
| Profit Margin | 2.07% |
| EBITDA Margin | 13.85% |
| EBIT Margin | 11.36% |
| FCF Margin | 25.10% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 9.06% |
| Shareholder Yield | 9.06% |
| Earnings Yield | 1.36% |
| FCF Yield | 16.55% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $3.95 |
| Price Target Difference | 13.18% |
| Analyst Consensus | Hold |
| Analyst Count | 14 |
| Revenue Growth Forecast (3Y) | 3.94% |
| EPS Growth Forecast (3Y) | 6.41% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.24 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |